Your session is about to expire
← Back to Search
CBD Oil for Post-Traumatic Stress Disorder
Study Summary
This trial is testing if CBD can help people with PTSD by seeing if it improves symptoms and how well they function. There are 3 groups- one receiving CBD isolate, one Broad Spectrum CBD, and a placebo group. They expect that the CBD groups will do better than the placebo group and that the Broad Spectrum group will do better than the Isolate group.
- Post Traumatic Stress Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your main mental health condition is Post-Traumatic Stress Disorder (PTSD) as defined by the DSM-5.You are able to use the internet.You have a history of alcohol or drug addiction within the last month.You are able to use the internet.You have experienced negative side effects from using CBD oil or other CBD products in the past.Your main mental health condition is diagnosed as PTSD according to the DSM-5 criteria.You are allergic to coconut oil.You have had a mental illness called psychosis in the past 6 months.You agree not to use any marijuana that is not part of the study during the study period.You attempted to harm yourself within the last 6 months.
- Group 1: CBD Isolate
- Group 2: CBD Broad Spectrum
- Group 3: Placebo oil
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the ultimate goal of this clinical experiment?
"This research is gauging its effectiveness with the CAPS-5 measure during post-treatment (week 9), one month (week 13) and three months (week 21). Secondary outcomes include changes from baseline in symptoms of depression, as assessed by PHQ-9; anxiety, determined using GAD-7; and further evaluation of depressive signs via QIDS assessments."
Is the minimum age requirement for this research experiment 18 or older?
"This research trial seeks to enroll patients between the ages of 18 and 70. Additionally, there are 58 studies available for minors and 380 trials that focus on elderly individuals."
Are there any precedents of CBD Isolate being used in prior clinical experiments?
"Presently, 79 CBD Isolate trials are in progress. Out of those studies, 16 have reached Phase 3 status with the bulk being located at Ribeirao Preto, Sao Paulo and 289 other sites across the globe also hosting research initiatives for this treatment."
Has the United States Food and Drug Administration sanctioned CBD Isolate?
"There is limited data suggesting the safety of CBD Isolate, which resulted in a score of 2 on our scale. This reflects that while there has been some research into its safety, none exists to support its efficacy."
Are there vacancies left for participants in this experiment?
"Affirmative. Per information on clinicaltrials.gov, the recruitment for this medical exploration is still open. It was initially posted January 15th 2020 and most recently edited October 3rd 2022 with a goal of recruiting 150 patients across one centre."
What is the enrollment rate for this investigation?
"Affirmative. According to clinicaltrials.gov, this research project is presently recruiting test subjects and was first posted on January 15th 2020 with the last edit being made on October 3rd 2022. The trial necessitates 150 participants from one centre."
Are there any eligibility criteria for entry into this clinical trial?
"This medical trial is recruiting 150 patients aged 18 to 70 who are suffering from stress or trauma-related disorders. Applicants must meet the DSM-5 criteria for PTSD, be fluent in English, possess transportation and internet access, agree to provide informed consent, and abstain from cannabis use throughout the study period."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger